DOI: 10.12890/2024_004670

Sweet syndrome presenting with features of cellulitis shortly after femoral angioplasty

Authors

  • Qi Wang Internal Medicine, Unity Hospital/Rochester Regional Health, Rochester, USA
  • John Sinclair Internal Medicine, Unity Hospital/Rochester Regional Health, Rochester, USA
  • Ayyappa Amaravadi Internal Medicine, Unity Hospital/Rochester Regional Health, Rochester, USA
  • Onovughe Aroriode Internal Medicine, Unity Hospital/Rochester Regional Health, Rochester, USA

jodiwang0816@gmail.com

Keywords

Sweet syndrome, neutrophilic dermatosis, angioplasty, autoinflammation

Abstract

Neutrophilic dermatosis, or Sweet syndrome, is a cutaneous disorder caused by neutrophilic infiltration in the upper dermis. It has been associated with medications, infections and malignancies but to date it has not been associated with femoral arterial angioplasty or stenting. We present the case of a 75-year-old female who, after angioplasty and stent placement of the right superficial femoral artery, developed right heel pain with ulceration that did not respond to broad antibiotics.
She underwent incision and drainage twice without improvement; both times produced negative cultures. She then underwent a punch biopsy by dermatology, which was consistent with acute spongiotic and other neutrophilic dermatoses. She was started on prednisone with immediate improvement of her symptoms. She was discharged to a rehabilitation centre with a prednisone taper and antibiotics. This report highlights the importance of maintaining Sweet syndrome on the differential for cellulitis as it is a rare mimicry of other infectious and non-infectious aetiologies, which are common in the perioperative space. Early treatment is crucial to improve symptoms, outcomes, healthcare cost and potentially the length of stay.

View the entire article

Downloads

References

  1. Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis 1986;37:167–174.
  2. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349–356.
  3. Cohen PR. Sweet’s syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.
  4. Cohen PR. Tattoo-associated Sweet syndrome. Dermatol Online J 2023;29.
  5. Kluger N, Del Giudice P. First case of Sweet’s syndrome after tattooing. Ann Dermatol Venereol 2022;149:279–280.
  6. Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet’s syndrome. Front Immunol 2019;10:414.
  7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.
  8. von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:535–556; quiz 557–560.
  9. Nofal A, Abdelmaksoud A, Amer H, Nofal E, Yosef A, Gharib K, et al. Sweet’s syndrome: diagnostic criteria revisited. J Dtsch Dermatol Ges. 2017;15:1081–1088.
  10. Orfaly VE, Shakshouk H, Heath M, Hamilton A, Ortega-Loayza AG. Sweet syndrome: a review of published cases. Dermatology 2023;239:664–669.

Published

2024-09-24

Issue

Vol. 11 No. 10 (2024)

Categories

How to Cite

1.
Wang Q, Sinclair J, Amaravadi A, Aroriode O. Sweet syndrome presenting with features of cellulitis shortly after femoral angioplasty. EJCRIM [Internet]. 2024 Sep. 24 [cited 2026 Nov. 3];11(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4670